Top Markets
#1 Black Phoenix Black Phoenix +354.01%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +73.69%
#4 Gold Park Gold Park +58.04%
#5 Acurast Acurast +39.86%
#6 OpenEden OpenEden +38.21%
#7 BasedHype BasedHype +27.22%
#8 Cryptopia Cryptopia +21.54%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.45%
#10 Avantis Avantis +17.36%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Rangering i aksjer #40630
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Aksjekurs
$0.00045794
Sist synkronisert: 2025-07-11
Markedsverdi
$107.51K
Endring (1 dag)
-36.01%
Endring (1 år)
0.00%
Land
DK
Handel Scandion Oncology A/S (SCOL)

Kategori

Healthcare
Aksjeprishistorikk for Scandion Oncology A/S (SCOL)
Høyeste sluttskurs: $0.00 den 2025-07-01

Laveste sluttskurs: $0.74 den 2018-11-01
Aksjeprishistorikk for Scandion Oncology A/S fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2025 -92.13%
2024 -96.87%
2023 -14.41%
2022 -80.44%
2021 -42.28%
2020 127.83%
2019 80.43%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE